1. Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol. Issue 1 (15th January 2021) Authors: Mansouri, Anita; McGregor, Naomi; Dunn, Rachel; Dobbie, Sam; Holmes, Jane; Collins, Linda; Nicum, Shibani Journal: BMJ open Issue: Volume 11:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol. Issue 1 (15th January 2021) Authors: Mansouri, Anita; McGregor, Naomi; Dunn, Rachel; Dobbie, Sam; Holmes, Jane; Collins, Linda; Nicum, Shibani Journal: BMJ open Issue: Volume 11:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol. Issue 1 (15th January 2021) Authors: Mansouri, Anita; McGregor, Naomi; Dunn, Rachel; Dobbie, Sam; Holmes, Jane; Collins, Linda; Nicum, Shibani Journal: BMJ open Issue: Volume 11:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Witness to the Revolution: Jean-Baptiste Louvet, 1760–1797. (24th February 2022) Authors: Dobbie, Sam Journal: French history Issue: Volume 36:Number 1(2022) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗